FDA 483 - Kabe Labortechnik Gmbh - January 09, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Kabe Labortechnik Gmbh in Numbrecht, Germany, from January 6-9, 2025, revealed significant deficiencies in their quality system. The firm failed to establish adequate procedures for design control, corrective and preventive actions, process validation, and supplier management. These issues indicate a systemic lack of control over critical manufacturing processes and product quality for devices like the Safe-T-Fill Capillary Blood Collection System.
ID · ca57f9d8-e9e7-4d94-b5bb-a6c800d0c1e2